Daiwa Securities Group
AVDL

Daiwa Securities Group’s Avadel Pharmaceuticals AVDL Stock Holding History

Daiwa Securities Group’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-332
Closed -$5K – 1365
2025
Q3 		$5K Hold
332
– – ﹤0.01% 1197
2025
Q2 		$3K Hold
332
– – ﹤0.01% 1186
2025
Q1 		$3K Hold
332
– – ﹤0.01% 1159
2024
Q4 		$3K Hold
332
– – ﹤0.01% 1186
2024
Q3 		$4K Hold
332
– – ﹤0.01% 1177
2024
Q2 		$5K Hold
332
– – ﹤0.01% 1195
2024
Q1 		$6K Buy
332
+87
+36% +$1.3K ﹤0.01% 1193
2023
Q4 		$3K Hold
245
– – ﹤0.01% 1239
2023
Q3 		$3K Hold
245
– – ﹤0.01% 1191
2023
Q2 		$4K Hold
245
– – ﹤0.01% 1192
2023
Q1 		$2K Hold
245
– – ﹤0.01% 1206
2022
Q4 		$2K Buy
245
+125
+104% +$877 ﹤0.01% 1213
2022
Q3 		$1K Hold
120
– – ﹤0.01% 1270
2022
Q2 		$0 Hold
120
– – ﹤0.01% 1357
2022
Q1 		$1K Hold
120
– – ﹤0.01% 1293
2021
Q4 		$1K Hold
120
– – ﹤0.01% 1326
2021
Q3 		$1K Hold
120
– – ﹤0.01% 1261
2021
Q2 		$1K Hold
120
– – ﹤0.01% 1181
2021
Q1 		$1K Hold
120
– – ﹤0.01% 1188
2020
Q4 		$1K Buy
+120
New +$751 ﹤0.01% 1166
2020
Q2 		– Sell
-46,100
Closed -$366K – 1204
2020
Q1 		$366K Buy
+46,100
New +$354K ﹤0.01% 733
2018
Q4 		– Sell
-227
Closed -$1K – 1145
2018
Q3 		$1K Hold
227
– – ﹤0.01% 1144
2018
Q2 		$1K Hold
227
– – ﹤0.01% 1161
2018
Q1 		$2K Buy
+227
New +$2K ﹤0.01% 1119

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Daiwa Securities Group's AVDL Position: Q4 2025 in Review

Daiwa Securities Group sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 332 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in AVDL in Q1 2018 and held it in 24 quarters. The position peaked at $366K in Q1 2020. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Daiwa Securities Group reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 332 Avadel Pharmaceuticals shares in Q4 2025, an estimated $5K.
  • Daiwa Securities Group first reported a position in Avadel Pharmaceuticals in Q1 2018 and held it in 24 quarters.
  • Daiwa Securities Group's Avadel Pharmaceuticals position peaked at $366K in Q1 2020.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.